These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 32156244)

  • 1. Selective Inhibition of Esophageal Cancer Stem-like Cells with Salinomycin.
    Zarei M; Jazi MS; Tajaldini M; Khosravi A; Asadi J
    Anticancer Agents Med Chem; 2020; 20(7):783-789. PubMed ID: 32156244
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Salinomycin exerts anticancer effects on human breast carcinoma MCF-7 cancer stem cells via modulation of Hedgehog signaling.
    Lu Y; Ma W; Mao J; Yu X; Hou Z; Fan S; Song B; Wang H; Li J; Kang L; Liu P; Liu Q; Li L
    Chem Biol Interact; 2015 Feb; 228():100-7. PubMed ID: 25499043
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A peptide-salinomycin conjugate with a bystander effect reduces the stemness characteristics of ovarian cancer cells and enhances drug sensitivity.
    Hao C; Chen P; Setrerrahmane S; Xu H
    Eur J Med Chem; 2024 Oct; 276():116701. PubMed ID: 39067438
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Poly(lactic-co-glycolic acid) nanoparticles conjugated with CD133 aptamers for targeted salinomycin delivery to CD133+ osteosarcoma cancer stem cells.
    Ni M; Xiong M; Zhang X; Cai G; Chen H; Zeng Q; Yu Z
    Int J Nanomedicine; 2015; 10():2537-54. PubMed ID: 25848270
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salinomycin effectively eliminates cancer stem-like cells and obviates hepatic metastasis in uveal melanoma.
    Zhou J; Liu S; Wang Y; Dai W; Zou H; Wang S; Zhang J; Pan J
    Mol Cancer; 2019 Nov; 18(1):159. PubMed ID: 31718679
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Salinomycin induces selective cytotoxicity to MCF-7 mammosphere cells through targeting the Hedgehog signaling pathway.
    Fu YZ; Yan YY; He M; Xiao QH; Yao WF; Zhao L; Wu HZ; Yu ZJ; Zhou MY; Lv MT; Zhang SS; Chen JJ; Wei MJ
    Oncol Rep; 2016 Feb; 35(2):912-22. PubMed ID: 26718029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and Anticancer Activity of Tertiary Amides of Salinomycin and Their C20-oxo Analogues.
    Czerwonka D; Urbaniak A; Sobczak S; Piña-Oviedo S; Chambers TC; Antoszczak M; Huczyński A
    ChemMedChem; 2020 Jan; 15(2):236-246. PubMed ID: 31702860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salinomycin possesses anti-tumor activity and inhibits breast cancer stem-like cells via an apoptosis-independent pathway.
    An H; Kim JY; Lee N; Cho Y; Oh E; Seo JH
    Biochem Biophys Res Commun; 2015 Oct; 466(4):696-703. PubMed ID: 26407842
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Salinomycin suppresses cancer cell stemness and attenuates TGF-β-induced epithelial-mesenchymal transition of renal cell carcinoma cells.
    Liu L; Wang Q; Mao J; Qin T; Sun Y; Yang J; Han Y; Li L; Li Q
    Chem Biol Interact; 2018 Dec; 296():145-153. PubMed ID: 30273566
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Single and double modified salinomycin analogs target stem-like cells in 2D and 3D breast cancer models.
    Urbaniak A; Reed MR; Fil D; Moorjani A; Heflin S; Antoszczak M; Sulik M; Huczyński A; Kupsik M; Eoff RL; MacNicol MC; Chambers TC; MacNicol AM
    Biomed Pharmacother; 2021 Sep; 141():111815. PubMed ID: 34130123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the autophagic flux by salinomycin in breast cancer stem-like/progenitor cells interferes with their maintenance.
    Yue W; Hamaï A; Tonelli G; Bauvy C; Nicolas V; Tharinger H; Codogno P; Mehrpour M
    Autophagy; 2013 May; 9(5):714-29. PubMed ID: 23519090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of hyaluronic acid functionalized carbon nanotubes loaded with salinomycin on gastric cancer stem cells.
    Yao HJ; Zhang YG; Sun L; Liu Y
    Biomaterials; 2014 Nov; 35(33):9208-23. PubMed ID: 25115788
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-Eradication of Breast Cancer Cells and Cancer Stem Cells by Cross-Linked Multilamellar Liposomes Enhances Tumor Treatment.
    Kim YJ; Liu Y; Li S; Rohrs J; Zhang R; Zhang X; Wang P
    Mol Pharm; 2015 Aug; 12(8):2811-22. PubMed ID: 26098197
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transforming growth factor-beta1 promotes the migration and invasion of sphere-forming stem-like cell subpopulations in esophageal cancer.
    Yue D; Zhang Z; Li J; Chen X; Ping Y; Liu S; Shi X; Li L; Wang L; Huang L; Zhang B; Sun Y; Zhang Y
    Exp Cell Res; 2015 Aug; 336(1):141-9. PubMed ID: 26096658
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Knockdown of TAZ decrease the cancer stem properties of ESCC cell line YM-1 by modulation of Nanog, OCT-4 and SOX2.
    Khosravi A; Jafari SM; Asadi J
    Gene; 2021 Feb; 769():145207. PubMed ID: 33031893
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymeric Micellar Formulation Enhances Antimicrobial and Anticancer Properties of Salinomycin.
    Sousa C; Gouveia LF; Kreutzer B; Silva-Lima B; Maphasa RE; Dube A; Videira M
    Pharm Res; 2019 Apr; 36(6):83. PubMed ID: 30989413
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phosphodiesterase 5/protein kinase G signal governs stemness of prostate cancer stem cells through Hippo pathway.
    Liu N; Mei L; Fan X; Tang C; Ji X; Hu X; Shi W; Qian Y; Hussain M; Wu J; Wang C; Lin S; Wu X
    Cancer Lett; 2016 Aug; 378(1):38-50. PubMed ID: 27179930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A medicinal chemistry perspective on salinomycin as a potent anticancer and anti-CSCs agent.
    Antoszczak M
    Eur J Med Chem; 2019 Feb; 164():366-377. PubMed ID: 30611056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting cancer stem cells expressing an embryonic signature with anti-proteases to decrease their tumor potential.
    Darini CY; Martin P; Azoulay S; Drici MD; Hofman P; Obba S; Dani C; Ladoux A
    Cell Death Dis; 2013 Jul; 4(7):e706. PubMed ID: 23828569
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Salinomycin, as an autophagy modulator-- a new avenue to anticancer: a review.
    Jiang J; Li H; Qaed E; Zhang J; Song Y; Wu R; Bu X; Wang Q; Tang Z
    J Exp Clin Cancer Res; 2018 Feb; 37(1):26. PubMed ID: 29433536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.